Laura Burkbauer1, Macy Goldbach1, Daniel I Hoffman1, Andreas Giannakou2, Rachel Dultz3, Ari D Brooks1, Dahlia M Sataloff4, Luke Keele5, Julia Tchou6. 1. Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. 2. Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA. 3. Department of Surgery, Penn Medicine Princeton Health, Princeton, NJ, USA. 4. Department of Surgery, Pennsylvania Hospital, Philadelphia, PA, USA. 5. Division of Epidemiology and Biostatistics, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. 6. Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Julia.tchou@pennmedicine.upenn.edu.
Abstract
BACKGROUND: Results of an earlier retrospective study from our institution suggested that patients with triple negative breast cancer (TNBC) who had preoperative MRI may have had an improved local recurrence rate (LRR) after breast conserving surgery (BCS). We aimed to clarify the impact of preoperative MRI on surgical outcomes in an expanded TNBC cohort treated by BCS in a contemporary era. METHODS: Our study cohort comprised 648 patients with TNBC who underwent BCS between 2009 and 2018. Demographic and clinical characteristics were compared between those with (n = 292, 45.1%) and without (n = 356, 54.9%) preoperative MRI. Multivariable logistic regression was performed to assess the association of preoperative MRI with surgical outcomes. RESULTS: The crude LRR of 3.5% was lower than previously reported. Univariable analyses demonstrated that the LRR and re-excision rates in the MRI and no-MRI groups were 3.4 and 3.7%, 21.6% and 27.2%, p = 0.876 and p = 0.10, respectively. Multivariable logistic regression analyses demonstrated that preoperative MRI was not associated with a lower LRR: odds ratio (OR) = 1.42 (p = 0.5). During our study period, new margin guidelines and shave margins practice were adopted in 2014 and 2015. To account for their effects, the year of diagnosis/surgery and other clinical variables were adjusted in multivariable logistic regression and inverse probability weighting models to demonstrate that preoperative MRI remained associated with a lower re-excision risk, OR 0.56, p = 0.04l; and a lower re-excision rate, 23.15% versus 36.0%, p < 0.01, respectively. CONCLUSIONS: Our findings suggested that patients with TNBC anticipating BCS may benefit from preoperative MRI.
BACKGROUND: Results of an earlier retrospective study from our institution suggested that patients with triple negative breast cancer (TNBC) who had preoperative MRI may have had an improved local recurrence rate (LRR) after breast conserving surgery (BCS). We aimed to clarify the impact of preoperative MRI on surgical outcomes in an expanded TNBC cohort treated by BCS in a contemporary era. METHODS: Our study cohort comprised 648 patients with TNBC who underwent BCS between 2009 and 2018. Demographic and clinical characteristics were compared between those with (n = 292, 45.1%) and without (n = 356, 54.9%) preoperative MRI. Multivariable logistic regression was performed to assess the association of preoperative MRI with surgical outcomes. RESULTS: The crude LRR of 3.5% was lower than previously reported. Univariable analyses demonstrated that the LRR and re-excision rates in the MRI and no-MRI groups were 3.4 and 3.7%, 21.6% and 27.2%, p = 0.876 and p = 0.10, respectively. Multivariable logistic regression analyses demonstrated that preoperative MRI was not associated with a lower LRR: odds ratio (OR) = 1.42 (p = 0.5). During our study period, new margin guidelines and shave margins practice were adopted in 2014 and 2015. To account for their effects, the year of diagnosis/surgery and other clinical variables were adjusted in multivariable logistic regression and inverse probability weighting models to demonstrate that preoperative MRI remained associated with a lower re-excision risk, OR 0.56, p = 0.04l; and a lower re-excision rate, 23.15% versus 36.0%, p < 0.01, respectively. CONCLUSIONS: Our findings suggested that patients with TNBC anticipating BCS may benefit from preoperative MRI.
Authors: Neha Vapiwala; Wei-Ting Hwang; Carolyn J Kushner; Mitchell D Schnall; Gary M Freedman; Lawrence J Solin Journal: Cancer Date: 2016-12-16 Impact factor: 6.860
Authors: N H G M Peters; S van Esser; M A A J van den Bosch; R K Storm; P W Plaisier; T van Dalen; S C E Diepstraten; T Weits; P J Westenend; G Stapper; M A Fernandez-Gallardo; I H M Borel Rinkes; R van Hillegersberg; W P Th M Mali; P H M Peeters Journal: Eur J Cancer Date: 2010-12-30 Impact factor: 9.162
Authors: Anees B Chagpar; Brigid K Killelea; Theodore N Tsangaris; Meghan Butler; Karen Stavris; Fangyong Li; Xiaopan Yao; Veerle Bossuyt; Malini Harigopal; Donald R Lannin; Lajos Pusztai; Nina R Horowitz Journal: N Engl J Med Date: 2015-05-30 Impact factor: 91.245
Authors: Lindsay Turnbull; Sarah Brown; Ian Harvey; Catherine Olivier; Phil Drew; Vicky Napp; Andrew Hanby; Julia Brown Journal: Lancet Date: 2010-02-13 Impact factor: 79.321
Authors: Wendie A Berg; Lorena Gutierrez; Moriel S NessAiver; W Bradford Carter; Mythreyi Bhargavan; Rebecca S Lewis; Olga B Ioffe Journal: Radiology Date: 2004-10-14 Impact factor: 11.105
Authors: Wei-Tse Yang; Mark Dryden; Kristine Broglio; Michael Gilcrease; Shaheenah Dawood; Peter J Dempsey; Vicente Valero; Gabriel Hortobagyi; Deann Atchley; Banu Arun Journal: Breast Cancer Res Treat Date: 2007-11-17 Impact factor: 4.872
Authors: Yingbing Wang; Debra M Ikeda; Balasubramanian Narasimhan; Teri A Longacre; Richard J Bleicher; Sunita Pal; Roger J Jackman; Stefanie S Jeffrey Journal: Radiology Date: 2008-01-07 Impact factor: 11.105